MENU
RLAY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Relay Therapeutics (RLAY) Ownership - Who owns Relay Therapeutics?
Profile
Industry
N/A
Address
399 Binney Street
Phone
+1 617 370-8837
Employees
323
Web
https://www.relaytx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
753.22M
P/E Ratio
N/A
Total Cash
839.61M
Projected Growth
N/A
Total Debt
49.82M
Revenue
10.01M
Risk (Beta)
1.73
Dividend Yield
N/A
Total Cash/Share
5.02
Total Debt/Equity
N/A
Revenue/Share
0.08 USD as % of share price
Fundamentals
RLAY
Capitalization
753M
P/E Ratio
N/A
Risk (Beta)
1.73
Dividend Yield
N/A
Total Cash
840M
Total Cash/Share
5.02
Total Debt
49.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.08%
Revenue
10M
ROE
N/A
Book Value
839M
P/B Ratio
0.90
Cash Flow
N/A
Earnings
-2.61
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
167K
Current Ratio
18.42
Current Revenue Per Employee
32385.11
Dividends Per Share - Security
N/A
EBITDA
-389.45M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-37.58
Shares Held By Institutions
1.28B
Shares Outstanding - Current
167M
Total Liabilities
91.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-59.128
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage precision medicines company, which focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
399 Binney Street
Phone
+1 617 370-8837
Employees
323
Web
https://www.relaytx.com